Hosted on MSN2h
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Vertex, OneStream and Workiva see bullish views at Goldman despite impact on stock
Goldman Sachs said it reiterated Buy ratings on OneStream ( NASDAQ: OS ), Vertex ( NASDAQ: VERX) and Workiva ( NYSE: WK) ...
Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
Sionna Therapeutics recently secured an initial public offering (IPO) of $191m on the Nasdaq stock exchange, signalling ...
Anthropic AI releases Claude 3.7 Sonnet, their most AI advanced model yet
Anthropic AI has released their Claude 3.7 Sonnet, a hybrid reasoning model said to be their most advanced AI model yet.
The Nation UAE on MSN10h
Advanced solar solutions to support Pakistan's renewable energy transition
As the country faces significant energy challenges, including rising electricity prices, grid instability, and heavy reliance on fossil fuels, a shift towards renewable energy is gaining momentum.
Investing Snacks13h
Hedge Fund Trims Vertex Stake as Analysts Weigh In
Handelsbanken Fonder AB reduced its stake in Vertex Pharmaceuticals by 28.1% in Q4, selling 115,479 shares. The fund now owns ...
Business Wire17h
Accenture Helps Organizations Supercharge Growth and Customer Experiences with AI from Google Cloud and Salesforce
Accenture is helping organizations supercharge growth and customer experiences with AI from Google Cloud and Salesforce.
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...